Rate My Professor Shakila Thangaratinam

Her research portfolio focuses on enhancing maternal and perinatal health globally and nationally through clinical trials, advanced evidence synthesis methods like individual participant data meta-analyses, living systematic reviews, and network meta-analyses. Key areas include prediction and prevention of gestational diabetes, pre-eclampsia, seizures in pregnant women with epilepsy, lifestyle interventions for obesity, maternity safety, and addressing race/ethnic inequalities. She leads major international collaborations: IPPIC network across 21 countries involving 5.5 million pregnancies, i-WIP with 16 countries and 60,000 pregnancies, and PregCOV-19 living databases. Holding grants such as the NIHR Senior Investigator renewal (2024-2029) and EpiSafe (2023-2028), her 279 peer-reviewed publications boast an h-index of 72 and over 34,000 citations. Influential works include 'Effects of lifestyle interventions in pregnancy on gestational diabetes: individual participant data and network meta-analysis' (BMJ, 2026), 'Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy' (BMJ, 2020), and 'Pulse oximetry screening for critical congenital heart defects in asymptomatic newborn babies' (Lancet, 2012). Her contributions have informed over 130 policy documents and guidelines on COVID-19 in pregnancy, gestational diabetes, pre-eclampsia, pulse oximetry in newborns, and epilepsy in pregnancy.